Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 11, 2022
Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021Kuan-Yin Lin, Ming-Ju Hsieh, Sui-Yuan Chang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 27, 2018
Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settingsCheng-Pin Chen, Chien-Yu Cheng, Huachun Zou, et al.Journal of the International AIDS Society|November 15, 2014
Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)Chien-Yu Cheng, Yu-Zhen Luo, Pei-Ying Wu, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 19, 2024
Drug monitoring was conducted for rifapentine among people with HIV receiving dolutegravir containing antiretroviral therapy and latent tuberculosis treatmentJeng-Hung Chen, Yi-Chun Lin, Cheng-Pin Chen, et al.BMC Infectious Diseases|May 25, 2010
Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapyChien-Yu Cheng, Mao-Yuan Chen, Szu-Min Hsieh, et al.Journal of Infection in Developing Countries|May 1, 2016
Prospective antimicrobial audit and feedback did not decrease case fatality: Experiences from a hospital in northern TaiwanChien-Yu Cheng, Chien-Yu Lee, Min-Wen Wu, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 12, 2025
Risk factors for mpox infection among MSM with STIs in northern Taiwan, 2022-2024Wei-Yen Chen, Shu-Hsing Cheng, Cheng-Pin Chen, et al.Microbiology Spectrum|June 15, 2022
Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging VariantsCheng-Pin Chen, Kuan-Ying A Huang, Shin-Ru Shih, et al.Human Vaccines & Immunotherapeutics|November 29, 2024
Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 studyChien-Yu Cheng, Ying-Shih Su, Chyi-Liang Chen, et al.Plos One|December 31, 2024
Oncogenic human papillomavirus and anal microbiota in men who have sex with men and are living with HIV in Northern TaiwanShu-Hsing Cheng, Yu-Chen Yang, Cheng-Pin Chen, et al.Pageof 9